The board of directors of Bliss GVS Pharma Limited meeting held on May 11, 2023, recommended final dividend of 50% i.e. 0.50 paisa per equity share having face value of INR 1/- each for the financial year ended March 31, 2023, subject To Approve the shareholders in the forthcoming 38th Annual General Meeting of the Company. The Final Dividend if approved by the shareholders will be pald to the Shareholders whose names appear In the Register of Members or the Company as on Record Date i.e. July 12, 2023.